RA PHARMACEUTICALS, INC. Operating Income
RA PHARMACEUTICALS, INC. reported Operating Income of -$106.98 million for the 12-month period ending 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2020-02-27
- RA PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2019-12-31 was -$37.83M.
- RA PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2019-09-30 was -$26.22M.
- RA PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2019-06-30 was -$22.85M.
- RA PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2019-03-31 was -$20.09M.
- RA PHARMACEUTICALS, INC. operating income (loss) for fiscal 2019 was -$106.98M.
- RA PHARMACEUTICALS, INC. operating income (loss) for fiscal 2018 was -$66.39M.
- RA PHARMACEUTICALS, INC. operating income (loss) for fiscal 2017 was -$55.03M.
- RA PHARMACEUTICALS, INC. operating income (loss) for fiscal 2016 was -$28.02M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2019-12-31 | -$37.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$64.04M derived: sum of 2 quarters · filed 2020-02-27 | -$86.89M derived: sum of 3 quarters · filed 2020-02-27 | -$106.98M 10-K · filed 2020-02-27 |
| 2019-09-30 | -$26.22M 10-Q · filed 2019-11-07 | -$49.06M derived: sum of 2 quarters · filed 2019-11-07 | -$69.15M 10-Q · filed 2019-11-07 | -$85.81M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-06-30 | -$22.85M 10-Q · filed 2019-08-07 | -$42.94M 10-Q · filed 2019-08-07 | -$59.59M derived: sum of 3 quarters · filed 2020-02-27 | -$76.47M derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-03-31 | -$20.09M 10-Q · filed 2019-05-09 | -$36.75M derived: sum of 2 quarters · filed 2020-02-27 | -$53.63M derived: sum of 3 quarters · filed 2020-02-27 | -$69.75M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-12-31 | -$16.66M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$33.54M derived: sum of 2 quarters · filed 2020-02-27 | -$49.66M derived: sum of 3 quarters · filed 2020-02-27 | -$66.39M 10-K · filed 2020-02-27 |
| 2018-09-30 | -$16.88M 10-Q · filed 2019-11-07 | -$33.01M derived: sum of 2 quarters · filed 2019-11-07 | -$49.73M 10-Q · filed 2019-11-07 | -$65.05M derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$16.13M 10-Q · filed 2019-08-07 | -$32.85M 10-Q · filed 2019-08-07 | -$48.17M derived: sum of 3 quarters · filed 2019-08-07 | -$63.59M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | -$16.72M 10-Q · filed 2019-05-09 | -$32.05M derived: sum of 2 quarters · filed 2019-05-09 | -$47.46M derived: sum of 3 quarters · filed 2019-05-09 | -$60.27M derived: sum of 4 quarters · filed 2019-05-09 |
| 2017-12-31 | -$15.32M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$30.74M derived: sum of 2 quarters · filed 2019-03-07 | -$43.55M derived: sum of 3 quarters · filed 2019-03-07 | -$55.03M 10-K · filed 2019-03-07 |
| 2017-09-30 | -$15.41M 10-Q · filed 2018-11-07 | -$28.23M derived: sum of 2 quarters · filed 2018-11-07 | -$39.71M 10-Q · filed 2018-11-07 | -$50.70M derived: sum of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | -$12.81M 10-Q · filed 2018-08-08 | -$24.29M 10-Q · filed 2018-08-08 | -$35.29M derived: sum of 3 quarters · filed 2018-08-08 | -$43.41M derived: sum of 4 quarters · filed 2018-08-08 |
| 2017-03-31 | -$11.48M 10-Q · filed 2018-05-09 | -$22.47M derived: sum of 2 quarters · filed 2018-05-09 | -$30.59M derived: sum of 3 quarters · filed 2018-05-09 | -$35.14M derived: sum of 4 quarters · filed 2018-05-09 |
| 2016-12-31 | -$10.99M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$19.11M derived: sum of 2 quarters · filed 2018-03-14 | -$23.66M derived: sum of 3 quarters · filed 2018-03-14 | -$28.02M 10-K · filed 2018-03-14 |
| 2016-09-30 | -$8.12M 10-Q · filed 2017-11-09 | -$12.67M derived: sum of 2 quarters · filed 2017-11-09 | -$17.03M 10-Q · filed 2017-11-09 | -$21.52M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | -$4.55M 10-Q · filed 2017-08-09 | -$8.91M 10-Q · filed 2017-08-09 | -$13.40M derived: sum of 3 quarters · filed 2018-03-14 | -$16.87M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | -$4.36M 10-Q · filed 2017-05-11 | -$8.85M derived: sum of 2 quarters · filed 2018-03-14 | -$12.32M derived: sum of 3 quarters · filed 2018-03-14 | |
| 2015-12-31 | -$4.49M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | -$7.96M derived: sum of 2 quarters · filed 2018-03-14 | -$13.36M 10-K · filed 2018-03-14 | |
| 2015-09-30 | -$3.47M 10-Q · filed 2016-11-29 | -$8.87M 10-Q · filed 2016-11-29 | ||
| 2014-12-31 | -$7.11M 10-K · filed 2017-03-06 |